High Growth Tech Stocks to Watch in October 2024

In This Article:

The United States market has remained flat over the last week but is up 38% over the past year with earnings expected to grow by 15% annually. In this context, high growth tech stocks that exhibit robust innovation and scalability potential are particularly noteworthy as they can capitalize on these favorable economic conditions.

Top 10 High Growth Tech Companies In The United States

Name

Revenue Growth

Earnings Growth

Growth Rating

Super Micro Computer

20.86%

27.98%

★★★★★★

Sarepta Therapeutics

23.67%

43.83%

★★★★★★

TG Therapeutics

28.39%

43.54%

★★★★★★

Invivyd

42.91%

70.39%

★★★★★★

Ardelyx

27.19%

66.44%

★★★★★★

Amicus Therapeutics

20.33%

62.45%

★★★★★★

Travere Therapeutics

27.74%

70.00%

★★★★★★

Seagen

22.57%

71.80%

★★★★★★

MediaAlpha

22.72%

61.31%

★★★★★★

ImmunoGen

26.00%

45.85%

★★★★★★

Click here to see the full list of 250 stocks from our US High Growth Tech and AI Stocks screener.

Here's a peek at a few of the choices from the screener.

MeiraGTx Holdings

Simply Wall St Growth Rating: ★★★★★☆

Overview: MeiraGTx Holdings plc is a clinical-stage gene therapy company dedicated to developing treatments for patients with serious diseases, with a market capitalization of $475.23 million.

Operations: The company focuses on the biotechnology sector, specifically startups, generating $8.12 million in revenue from this segment.

MeiraGTx Holdings, despite its unprofitable status, is poised for significant growth with a projected revenue increase of 40.5% per year, outpacing the US market average of 8.9%. This biotech firm's commitment to innovation is evident in its R&D spending trends which align closely with its strategic goals in genetic medicines. Recently, MeiraGTx reported promising results from a Parkinson’s disease study, enhancing its credibility and potential market impact. However, financial stability remains a concern as evidenced by a net loss widening to $69.06 million in the first half of 2024 from $59.95 million the previous year. The company also increased shareholder dilution through a recent $50 million equity offering at $4 per share—actions that reflect both challenges and aggressive pursuits for future profitability and growth within high-stakes biotechnology sectors.

NasdaqGS:MGTX Revenue and Expenses Breakdown as at Oct 2024
NasdaqGS:MGTX Revenue and Expenses Breakdown as at Oct 2024

Taboola.com

Simply Wall St Growth Rating: ★★★★☆☆

Overview: Taboola.com Ltd. operates an artificial intelligence-based algorithmic engine platform across various international markets, with a market cap of $1.23 billion.